« Previous
Next »
Nanomedicine: Nanotechnology, Biology and Medicine
Volume 4, Issue 4
, Pages
295-301
, December 2008
Mesothelin is a specific biomarker of invasive cancer in the Barrett-associated adenocarcinoma progression model: translational implications for diagnosis and therapy
To access this article, please choose from the options below
This work is supported by the D'Amato Foundation. K.T.Y, H.D., G.X., P.N.P., and A.M. are supported by National Cancer Institute grant R01CA119397.
PII: S1549-9634(08)00091-9
doi: 10.1016/j.nano.2008.06.006
© 2008 Elsevier Inc. All rights reserved.
« Previous
Next »
Nanomedicine: Nanotechnology, Biology and Medicine
Volume 4, Issue 4
, Pages
295-301
, December 2008
